Hericium Erinaceus Mycelium and Probiotic of the Grape King Bio on Symptoms of Premenstrual Syndrome
NCT ID: NCT05443477
Last Updated: 2022-07-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
105 participants
INTERVENTIONAL
2021-06-08
2023-01-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effectiveness of Chinese Medicine Nuan-gong-ye on Primary Dysmenorrhea
NCT06295822
A Preliminary Study on the Efficacy of Danggui Shaoyao San and Cuscuta Chinensis in Patients with Primary Dysmenorrhea
NCT06730282
Chinese Herbal Medicine for Gynecologic Patients
NCT06187376
Using a Herbal Remedy Extract for the Treatment of Endometriosis Symptoms
NCT04493476
Clinical Trial of Experienced Chinese Herbal Formulas on Different Types of Precocious Puberty
NCT02650141
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Participants met the inclusion criteria, ie: age 20\~45 yr and a regular menstrual cycle (21\~35 days per cycle) were recruited through advertisements posted around the Chun Shan Medical university campus. In screening phase of this study, affective and one somatic symptom in before onset of menstruation in two consecutive cycles and was not affected by depression or anxiety disorder, she is examined by the Attending Physician of the Obstetrics and Gynecology Department to diagnosed a patient with premenstrual syndrome. In the intervention phase of this study, 105 eligible participant were randomly divided into intervention (Grape King Hericium erinaceus Mycelium Capsules and Grape King Probiotic Capsules) and control groups (n=35/group). Both subjects and researchers were blind to the treatment assignment until the statistical analysis was completed. All participants received two oral capsules containing Hericium erinaceus Mycelium, probiotics or placebo every day for the 3 months. The capsules of intervention supplementations and placebo provided by Grape King Biotechnology Inc in identical appearance and package to guarantee the blindness.
Data collection A validated semi-quantitative Food Frequency Questionnaire was used to obtain daily nutritional values of participants. To assess the symptoms of PMS, all subjects need to fill out daily record of severity of problems on a daily basis in the 3 months of intervention period and 6 months after the intervention. In the 0, 1, 3 months of intervention, the anthropometric parameters and body composition were measured by using bioelectrical impedance analysis method ( MC-980 MA PLUS, TANITA BIA Technology). In the 0, 1, 3 months of intervention, venous blood samples were taken from all subjects for measuring the marks of oxidative stress and inflammation.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Hericium Erinaceus Mycelium
patients with premenstrual syndrome received supplementation of Hericium Erinaceus Mycelium capsules
Hericium Erinaceus Mycelium
participants received two oral capsules containing Hericium erinaceus Mycelium every day for the 3 months.
Probiotic
patients with premenstrual syndrome received supplementation of Probiotic capsules
Probiotic
participants received two oral capsules containing Probiotic powder every day for the 3 months.
control
patients with premenstrual syndrome received supplementation of placebo capsules
control
participants received two oral capsules containing control powder every day for the 3 months.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Hericium Erinaceus Mycelium
participants received two oral capsules containing Hericium erinaceus Mycelium every day for the 3 months.
Probiotic
participants received two oral capsules containing Probiotic powder every day for the 3 months.
control
participants received two oral capsules containing control powder every day for the 3 months.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. The menstrual cycle is 21\~35 days/time
3. PMS diagnosed by an obstetrician
4. Willing to sign the subject's consent form
Exclusion Criteria
2. Those have a surgery in the last 6 months
3. Those use of probiotics, estrogen and birth control pills
4. Body mass index \> 39 kg/m2, smoking, drinking
5. Death of a close relative and other stressful events within the last 6 months
20 Years
45 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chung Shan Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kai-Li Liu, PhD
Role: STUDY_CHAIR
Department of Nutrition, Chung Shan Medical University, Taichung, Taiwan
Man-Jung Hung, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Department of Medicine, Chung Shan Medical University, Taichung, Taiwan
Yi-Chin Lin, PhD
Role: PRINCIPAL_INVESTIGATOR
Department of Nutrition, Chung Shan Medical University, Taichung, Taiwan
Pey-Ling Shieh Shieh, PhD
Role: PRINCIPAL_INVESTIGATOR
Department of Psychology, Chung Shan Medical University, Taichung, Taiwan
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kai-Li Liu
Taichung, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Duvan CI, Cumaoglu A, Turhan NO, Karasu C, Kafali H. Oxidant/antioxidant status in premenstrual syndrome. Arch Gynecol Obstet. 2011 Feb;283(2):299-304. doi: 10.1007/s00404-009-1347-y. Epub 2010 Jan 19.
Danis P, Drew A, Lingow S, Kurz S. Evidence-based tools for premenstrual disorders. J Fam Pract. 2020 Jan/Feb;69(1):E9-E17. No abstract available.
Endicott J, Nee J, Harrison W. Daily Record of Severity of Problems (DRSP): reliability and validity. Arch Womens Ment Health. 2006 Jan;9(1):41-9. doi: 10.1007/s00737-005-0103-y. Epub 2005 Sep 20.
Sharifi-Rad J, Rodrigues CF, Stojanovic-Radic Z, Dimitrijevic M, Aleksic A, Neffe-Skocinska K, Zielinska D, Kolozyn-Krajewska D, Salehi B, Milton Prabu S, Schutz F, Docea AO, Martins N, Calina D. Probiotics: Versatile Bioactive Components in Promoting Human Health. Medicina (Kaunas). 2020 Aug 27;56(9):433. doi: 10.3390/medicina56090433.
Nagano M, Shimizu K, Kondo R, Hayashi C, Sato D, Kitagawa K, Ohnuki K. Reduction of depression and anxiety by 4 weeks Hericium erinaceus intake. Biomed Res. 2010 Aug;31(4):231-7. doi: 10.2220/biomedres.31.231.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BR-CT004
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
CS2-20104
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.